Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Humacyte Inc
(NQ:
HUMA
)
5.485
-0.565 (-9.34%)
Streaming Delayed Price
Updated: 3:09 PM EDT, Sep 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Humacyte Inc
< Previous
1
2
3
4
5
Next >
Stocks That Hit 52-Week Lows On Wednesday
November 16, 2022
On Wednesday, 70 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
November 15, 2022
On Tuesday, 34 companies set new 52-week lows.
Via
Benzinga
Humacyte Posts Preclinical Data Of Small-Diameter Human Acellular Vessel In Bypass Grafting
January 28, 2022
Humacyte Inc (NASDAQ: HUMA) has announced
Via
Benzinga
Humacyte Third Quarter 2022 Financial Results and Business Update
November 10, 2022
From
Humacyte, Inc
Via
GlobeNewswire
Humacyte Presents Six-Month Human Acellular Vessel™ (HAV™) Coronary Artery Bypass Graft (CABG) Data at the American Heart Association Scientific Sessions 2022 Meeting
November 07, 2022
From
Humacyte, Inc
Via
GlobeNewswire
Humacyte to Present Third Quarter Financial Results and Provide Corporate Update on November 10, 2022
November 03, 2022
From
Humacyte, Inc
Via
GlobeNewswire
Livent, Amgen And Some Other Big Stocks Moving Lower On Monday
September 12, 2022
U.S. stocks traded higher, with the Dow Jones gaining more than 250 points on Monday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Humacyte Earnings Perspective: Return On Invested Capital
September 09, 2022
According to Benzinga Pro, during Q2, Humacyte (NASDAQ:HUMA) earned $36.87 million, a 285.9% increase from the preceding quarter. Humacyte also posted a total of $1.30 million in sales, a 458.37%...
Via
Benzinga
Earnings Scheduled For August 12, 2022
August 12, 2022
Companies Reporting Before The Bell • NeoGenomics (NASDAQ:NEO) is projected to report quarterly earnings at $0.44 per share on revenue of $218.26 million.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
June 06, 2022
Via
Benzinga
41 Stocks Moving In Monday's Mid-Day Session
May 16, 2022
Gainers Data Storage Corporation (NASDAQ: DTST) shares jumped 51.1% to $3.4750 after the company reported better-than-expected Q1 financial results.
Via
Benzinga
Why FlexShopper Surged Over 47%; Here Are 104 Biggest Movers From Yesterday
August 12, 2022
Gainers Digital Media Solutions, Inc. (NYSE: DMS) jumped 78.8% to close at $2.11. Digital Media Solutions recently reported worse-than-expected Q2 EPS and sales results.
Via
Benzinga
95 Biggest Movers From Yesterday
June 07, 2022
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) shares gained 100.4% to close at $4.75 on Monday after the FDA granted clearance for the company's pūrgo technology, classifying it as a class II...
Via
Benzinga
52 Stocks Moving In Monday's Mid-Day Session
June 06, 2022
Gainers DiDi Global Inc. (NYSE: DIDI) jumped 51.4% to $2.80 after the Chinese government said the company can resume adding new users.
Via
Benzinga
Earnings Scheduled For May 13, 2022
May 13, 2022
Companies Reporting Before The Bell • Codere Online Luxembourg (NASDAQ:CDRO) is estimated to report quarterly loss at $0.13 per share on revenue of $20.08 million.
Via
Benzinga
73 Biggest Movers From Yesterday
May 17, 2022
Gainers AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) shares jumped 65.9% to close at $2.77 on Monday after gaining around 10% on Friday.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
April 19, 2022
Gainers
Via
Benzinga
Humacyte's Return On Capital Employed Insights
March 30, 2022
Pulled from Benzinga Pro data, Humacyte (NASDAQ:HUMA) posted Q4 earnings of $42.59 million, an increase from Q3 of 234.92%. Sales dropped to $177.00 thousand, a 26.56% decrease between quarters.
Via
Benzinga
The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia
March 29, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
How To Attend Humacyte Q4 2021 Earnings Conference Call
March 22, 2022
Humacyte (NASDAQ:HUMA) will host a conference call at 08:00 AM ET on March 29, 2022, to discuss Q4 2021 earnings results. How to Attend Humacyte (HUMA) Conference Call Follow this...
Via
Benzinga
Humacyte's Human Acellular Vessel Shows Long Term Benefit In Hemodialysis Patients
February 28, 2022
Humacyte Inc (NASDAQ: HUMA) announced five-year data from a Phase 2 trial of Human Acellular Vessel (HAV) for arteriovenous (AV) access in hemodialysis. In the...
Via
Benzinga
Earnings Scheduled For March 29, 2022
March 29, 2022
Companies Reporting Before The Bell • 36KR Holdings (NASDAQ:KRKR) is projected to report quarterly loss at $0.02 per share on revenue of $15.62 million.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2021
September 22, 2021
Upgrades Argus Research upgraded the previous rating for Simon Property Group Inc (NYSE:
Via
Benzinga
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
March 27, 2022
Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2021
September 16, 2021
Upgrades For Signet Jewelers Ltd (NYSE:
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
January 05, 2022
Before 10 am on Wednesday, 99 companies set new 52-week lows. Facts of Interest About Today's 52-Week Lows: Sea (NYSE:SE) was the largest firm by market cap to set a...
Via
Benzinga
Stocks Hitting New 52-Week Lows Today
January 03, 2022
On Monday morning, 60 companies achieved new lows for the year. Points of Interest From Today's 52-Week Lows And Highs: Ginkgo Bioworks Holdings (NYSE:DNA) was...
Via
Benzinga
64 Biggest Movers From Yesterday
November 02, 2021
Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares climbed 137.4% to close at $6.03 on Monday on abnormally-high volume. The stock is seeing increased interest by traders on...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 29, 2021
October 29, 2021
Upgrades For Preferred Bank (NASDAQ:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 24, 2021
September 24, 2021
Upgrades Berenberg upgraded the previous rating for Tenable Holdings Inc (NASDAQ:
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.